Michael Soulen, MD

Radiology & Surgery, Director of Interventional Oncology, Abramson Cancer Center, University of Pennsylvania

Dr. Michael Soulen is Professor of Radiology and Surgery and Director of Interventional Oncology at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, where he has been on the faculty for 25 years.

Dr. Soulen is a graduate of Yale University and the University of Pennsylvania School of Medicine. He was Chief Resident in Radiology at The Johns Hopkins Hospital, followed by clinical and research Fellowships at Thomas Jefferson University Hospital before coming to Penn.

A world-renowned expert in minimally-invasive image-guided cancer therapy, he has a large practice in embolization and ablation of liver malignancies, particularly NETs, colorectal cancer, and primary liver cancers. Research interests span genomic and metabolomics profiling of liver tumors under embolic stress, novel ultrasound contrast agents for drug delivery, and clinical trials of embolotherapies, and new integrations of embolotherapy with chemotherapy and radiation therapy. He is the global PI for the RETNET study, the first prospective trial comparing different types of embolotherapy for NET liver metastases.